Abstract: The present invention relates to a chemical conversion process, preferably an isomerization process, for at least one hydrocarbon in the presence of an ionic liquid. The chemical conversion is performed in a dispersion, with dispersion of the hydrocarbon (phase (B)) in the ionic liquid (phase (A)) in the dispersion, the volume ratio of phase (A) to phase (B) being in the range from 2.5 to 4:1 [vol/vol].

Abstract: Liquid precursor compositions are provided, along with methods of preparing the liquid precursor compositions, and methods for forming layers using the liquid precursor composition, for example in vapor deposition processes such as CVD and ALD. In some embodiments, the liquid precursor compositions comprise a metal compound of the formula M(DAD)2, where M is Co or Ni and DAD is a diazadiene ligand.

Abstract: This invention relates to a method of hydrolysis of the peptide bond between R1 and B in a specific designed amino acid sequence R1BXJZR3R2, where R1 represents a polypeptide of interest, R2 represents a sequence capable of specific binding to another component or molecule or another domain which needs to be cleaved, R3 represents an optional short peptide sequence, B represents a residue capable of accepting an acyl group, J represents a residue capable of metal ion binding, and X and Z represent amino acid residues, wherein the said method is based on a novel molecular mechanism of peptide bond hydrolysis, occurring in a specific complex of this metal ion with the BXJZ sequence. This method can be used to remove BXJZR3R2 domains in recombinant polypeptides, such as sequences capable of specific binding to another component or molecule to yield pure, unmodified R1 polypeptides of interest.

Abstract: Novel intercalation electrode materials including ternary acetylides of chemical formula: AnMC2 where A is alkali or alkaline-earth element; M is transition metal or metalloid element; C2 is reference to the acetylide ion; n is an integer that is 0, 1, 2, 3 or 4 when A is alkali element and 0, 1, or 2 when A is alkaline-earth element. The alkali elements are Lithium (Li), Sodium (Na), Potassium (K), Rubidium (Rb), Cesium (Cs) and Francium (Fr). The alkaline-earth elements are Berilium (Be), Magnesium (Mg), Calcium (Ca), Strontium (Sr), Barium (Ba), and Radium (Ra). M is a transition metal that is any element in groups 3 through 12 inclusive on the Periodic Table of Elements (elements 21 (Sc) to element 30 (Zn)). In another exemplary embodiment, M is a metalloid element.

Abstract: The present invention relates to iron (III) complexes of the formula Fe(L)x(Y)3-x, where the ligand L has the formula (I). Such complexes are especially suitable as a catalyst for two-component polyurethane compositions. The invention also relates to two-component polyurethane compositions comprising at least one polyisocyanate as the first component, at least one polyol as the second component and at least one iron (III) complex of this kind as a catalyst. In addition, the invention relates to various uses of these two-component polyurethane compositions.

Abstract: The present invention relates to an (amide amino alkane) metal compound represented by the formula (1): wherein M represents a metal atom; R1 represents a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms; R2 and R3 may be the same as, or different from each other, and each independently represents a linear or branched alkyl group having 1 to 3 carbon atoms, or R2 and R3 may form a substituted or unsubstituted 5- or 6-membered ring together with the nitrogen atom to which they are bound; Z represents a linear or branched alkylene group having 1 to 10 carbon atoms (a part of which may optionally form a ring); and n represents a number of the ligands, which is equal to the valence of the metal (M), and represents an integer of from 1 to 3; with the proviso that the metal compounds in which M is Li (Lithium), Be (Beryllium), Ge (Germanium) or Nd (Neodymium) are excluded; the metal compounds in which M is Mg (Magnesium) and R1 is methyl group are excluded; the metal compounds in which M i

Abstract: Disclosed are magnetic nanoparticles and methods of using magnetic nanoparticles for selectively removing biologics, small molecules, analytes, ions, or other molecules of interest from liquids.

Abstract: A composition is capable of curing via condensation reaction. The composition uses a new condensation reaction catalyst. The new condensation reaction catalyst is used to replace conventional tin catalysts. The composition can react to form a gum, gel, rubber, or resin.

Abstract: A method for ameliorating and/or preventing chronic kidney disease includes administering to a subject in need thereof an agent containing 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt thereof as an active ingredient. Preferably, these ALAs contain a metal-containing compound, such as sodium ferrous citrate. The above-mentioned ALAs, ALA; various esters, such as ALA methylester, ALA ethylester, ALA propylester, ALA butylester, and ALA pentylester; and hydrochlorides, phosphates, and sulfates, and the like of these ALA esters are preferred examples.

Abstract: Disclosed are water-soluble nanoparticles. The water-soluble nanoparticles are each surrounded by a multifunctional group ligand including an adhesive region, a cross linking region, and a reactive region. In the water-soluble nanoparticles, the cross-linking region of the multifunctional group ligand is cross-linked with another cross-linking region of a neighboring multifunctional group ligand.

Abstract: The present invention is directed to a compound comprising a bis[thiohydrazide amide] or a deprotonated form thereof, complexed to a transition metal cation, wherein the bis[thiohydrazide amide] is represented by Structural Formula (I): or a prodrug, isomer, ester, salt, hydrate, solvate, polymorph or a deprotonated form thereof. The present invention also provides a pharmaceutical composition comprising a compound of the invention and method of use thereof.

Abstract: A coordination complex having a physiologically acceptable pKa includes a metal and a biologically active agent. The pKa of the coordination complex is less than the pKa of the biologically active agent. A pharmaceutical solution for treating a patient includes a coordination complex and water, wherein the coordination complex is at least partially soluble in the water at physiological pH and in a therapeutically efficacious concentration. A method for treating a patient includes administering a pharmaceutical solution including a coordination complex and water to a patient in need of a biologically active agent.

Abstract: A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation reaction. The composition is capable of reacting via hydrosilylation reaction to form a reaction product, such as a silane, a gum, a gel, a rubber, or a resin. Ingredient (A) contains a metal-ligand complex that can be prepared by a method including reacting a metal precursor and a ligand.

Abstract: A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation reaction. The composition is capable of reacting via hydrosilylation reaction to form a reaction product, such as a silane, a gum, a gel, a rubber, or a resin.

Abstract: This disclosure relates to graphene derivatives, as well as related devices including graphene derivatives and methods of using graphene derivatives.

Abstract: There is provided a heat storage material capable of recovering/storing thermal energy such as exhaust heat energy or sunlight, and a heat utilization system using the same. The heat storage material of the present invention comprises a complex compound of the formula (I), wherein, R, R?, A, B, C, D, A?, B?, C? and D? are as defined herein.

Abstract: A preparation process for a cyclic conjugated polymer, includes the steps of deprotonating a monohalogenated cyclic conjugated compound of a 5- to 7-membered ring using a deprotonation catalyst comprising secondary amine represented by R1NHR2 (R1 and R2 are the same or different and are each a branched or cyclic alkyl group of 1 to 15 carbon atoms or a phenyl group) and a Grignard reagent represented by R3MgX (X is a halogen atom selected from chlorine, bromine and iodine, and R3 is a straight-chain or branched alkyl group of 1 to 6 carbon atoms) and polymerizing the deprotonated monohalogenated cyclic conjugated compound.

Abstract: Anticaking agents for inhibiting or preventing caking of inorganic salt granules are provided. The anticaking agents comprise a coordination complex of iron and a salt anion of an organic acid, wherein the salt anion is selected from the group consisting of malate, polyacrylate, diphosphonate, and mixtures thereof. Free-flowing, solid salt compositions resistant to caking are also described herein, along with methods of melting ice and/or snow on a surface or inhibiting the accumulation or formation of ice and/or snow on a surface, and methods of preventing or inhibiting caking of solid inorganic salt granules.

Abstract: Novel metal complexes useful in the area of agriculture, notably as agents for treating metal deficiency. The novel metal complexes comprise at least one metal selected from the metal trace elements essential for the development of plants, at least one first ligand selected from the lignosulfonates, and derivatives thereof, and at least one second ligand selected from the multidentate organic ligands.

Abstract: The present invention relates generally to the field of nucleic acid purification. In particular, provided herein are micro particles and micro particle clusters for selective anion exchange of nucleic acids, and methods and kits useful for this purpose.

Abstract: A metal organic framework (MOF) material including a Brunauer-Emmett-Teller (BET) surface area greater than 7,010 m2/g. Also a metal organic framework (MOF) material including hexa-carboxylated linkers including alkyne bond. Also a metal organic framework (MOF) material including three types of cuboctahedron cages fused to provide continuous channels. Also a method of making a metal organic framework (MOF) material including saponifying hexaester precursors having alkyne bonds to form a plurality of hexa-carboxylated linkers including alkyne bonds and performing a solvothermal reaction with the plurality of hexa-carboxylated linkers and one or more metal containing compounds to form the MOF material.

Abstract: Novel families of tri-valent metal complexes including scandium, yttrium, lanthanum, cerium, praseodymium, neodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, aluminum, gallium, indium, manganese, antimony, bismuth; and of divalent metal complexes including magnesium, calcium, strontium, barium, manganese, cobalt, iron, nickel, ruthenium, copper, zinc, cadium are disclosed. These metal complexes can be used as precursors to deposit metal or metal oxide films in semi-conductor industries.

Abstract: A novel catalyst component for producing a crystalline ?-olefin polymer or ?-olefin/(meth)acrylate copolymer having few branches, especially a polymer having a high molecular weight, and a method for producing an ?-olefin polymer or an ?-olefin/(meth)acrylate copolymer using the catalyst component. A metal complex represented by the following general formula (D), as well as a method for producing an ?-olefin polymer and a method for producing an ?-olefin/(meth)acrylate copolymer using the metal complex.

Abstract: Embodiments of the invention relate to a method of making a mineral product. The method includes contacting a carboxylic acid and an inorganic mineral compound sufficient to form a solution, reacting the solution over a period of time sufficient to provide a mineral chelated compound, transferring the mineral chelated compound to one or more molds prior to the compound substantially solidifying and reducing the size of the mineral chelated compound sufficient to provide a rapidly soluble mineral chelated product.

Abstract: The present invention relates to an (amide amino alkane) metal compound represented by the formula (1): wherein M represents a metal atom; R1 represents a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms; R2 and R3 may be the same as, or different from each other, and each independently represents a linear or branched alkyl group having 1 to 3 carbon atoms, or R2 and R3 may form a substituted or unsubstituted 5- or 6-membered ring together with the nitrogen atom to which they are bound; Z represents a linear or branched alkylene group having 1 to 10 carbon atoms (a part of which may optionally form a ring); and n represents a number of the ligands, which is equal to the valence of the metal (M), and represents an integer of from 1 to 3; with the proviso that the metal compounds in which M is Li (Lithium), Be (Beryllium), Ge (Germanium) or Nd (Neodymium) are excluded; the metal compounds in which M is Mg (Magnesium) and R1 is methyl group are excluded; the metal compounds in which M i

Abstract: The present invention discloses metallic complexes based on hydroxyl-carbonyl fulvene ligands, their method of preparation and their use in the oligomerization or polymerization of ethylene and alpha-olefins.

Abstract: A formulation, comprising: a) at least one metal-ligand complex, wherein one or more ligands are selected from the group consisting of ?-diketonates, ?-ketoiminates, ?-ketoesterates, ?-diiminates, alkyls, carbonyls, alkyl carbonyls, cyclopentadienyls, pyrrolyls, alkoxides, amidinates, imidazolyls, and mixtures thereof; and the metal is selected from Group 2 to 16 elements of the Periodic Table of the Elements; and, b) at least one aminoether selected from the group consisting of R1R2NR3OR4NR5R6, R1OR4NR5R6, O(CH2CH2)2NR1, R1R2NR3N(CH2CH2)2O, R1R2NR3OR4N(CH2CH2)2O, O(CH2CH2)2NR1OR2N(CH2CH2)2O, and mixtures thereof, wherein R1-6 are independently selected from group consisting of C1-10 linear alkyl, C1-10 branched alkyl, C1-10 cyclic alkyl, C6-C10 aromatic, C1-10 alkylamine, C1-10 alkylaminoalkyl, C1-10 ether, C4-C10 cyclic ether, C4-C10 cyclic aminoether, and mixture thereof.

Abstract: A redox fuel cell comprising an anode and a cathode separated by an ion selective polymer electrolyte membrane; means for supplying a fuel to the anode region of the cell; means for supplying an oxidant to the cathode region of the cell; means for providing an electrical circuit between the anode and the cathode; a catholyte solution comprising a modified ferrocene species being at least partially reduced at the cathode in operation of the cell, and at least partially re-generated by reaction with the oxidant after such reduction at the cathode.

Abstract: The present invention relates to metal organic framework materials which possess anti-microbial properties. The present invention also provides methods of preparing such metal organic framework materials and uses of the metal organic framework materials to prevent or treat microbial infections, or provide surfaces which limit contamination by micro-organisms.

Abstract: The invention discloses the incorporation of nanostructured additives into high-performance, hydrogen-rich polymeric materials to provide radiation shields for use against Galactic Cosmic Radiation and Solar Energetic Particles as well as secondary particulate and electromagnetic radiation resulting from nuclear reactions within the shield. Nanostructured materials are defined as having at least one dimension in the nanometer range, and may include metallic and metal-oxide nanoparticles, nanotubes, nanoclays, coated polymeric nanoparticles and pairs of materials forming a nanostructured interface. Functionalization of additives is performed to increase their compatability with polymeric materials. Hydrogen-rich polymers refer to those having interstitial hydrogen or hydrogen-containing materials pendant to the polymer backbone.

Abstract: One aspect of the present invention relates to a method for the transition metal (e.g., Cu(I)) mediated amidation of C—H bonds using electron-rich aliphatic azides. In certain embodiments, the methods are useful for the C—H insertion of nitrenes generated and stabilized by a ?-diketiminato metal catalyst. In certain embodiments, said nitrenes are generated from organoazides, or by oxidation of the corresponding amine. Another aspect of the present invention relates to olefin aziridination using said ?-diketiminato metal catalysts. In addition, the methods of the present invention include stereoselective C—H bond aminations and olefin aziridinatons. In certain embodiments, the methods are conducted in an aerobic environment. In certain embodiments, the present invention relates to the use of O2 as an oxidant, wherein water is the byproduct of oxidation; this fact avoids the generation of toxic byproducts and renders the methods atom economical.

Abstract: Synthetic peptidomimetic derivatives and phenyl group derivatives of Fenretinide (4-HPR) are disclosed, as are their uses as therapeutic, diagnostic and imaging agents for cancer and other diseases.

Abstract: The present invention is directed to a compound comprising a bis[thiohydrazide amide] or a deprotonated form thereof, complexed to a transition metal cation, wherein the bis[thiohydrazide amide] is represented by Structural Formula (I): or a prodrug, isomer, ester, salt, hydrate, solvate, polymorph or a deprotonated form thereof. The present invention also provides a pharmaceutical composition comprising a compound of the invention and method of use thereof.

Abstract: A compound comprising a class of sulfonated triorganophosphine compounds of formula R1R2P—R3[—O—(CH2)n—(SO3M)]m, wherein the R1 and R2 are selected individually from alkyl, aralkyl, and alicyclic groups, wherein R3 represents a divalent or polyvalent alkylene or alicyclic radical that is bonded to the phosphorus atom and to one or more sulfonate substituents via an alkylether link, and further wherein R3 does not contain any aryl moieties; n is an integer reflecting a number of methylene groups in the alkylether link; M represents a monovalent cation; and m is an integer representing a total number of sulfonated alkylether substituents. The compound is useful as a ligand in transition metal-ligand complex catalysts that are capable of catalyzing the hydroformylation of an olefinically-unsaturated compound with carbon monoxide and hydrogen to form one or more corresponding aldehyde products.

Abstract: The present invention discloses metallic complexes based on carbonylamino fulvene ligands; their method of preparation and their use in the oligomerisation or polymerisation of ethylene and alpha-olefins.

Abstract: A surface modified nanoparticle includes a nanoparticle and a phenol compound used for modifying the nanoparticle. The phenol compound has a formula of (a) or (b), wherein n=1˜9, X is selected from the group consisted of NH2, OH, PH4, COOH and SH, R1 is selected from the group consisted of C1-C5 alkyl group, aryl group, alkenyl group, alkynyl group, alkylamino group and alkoxy group. Each carbon atom of the phenol group may be independently substituted or non-substituted. The substituent of the carbon atom of the phenol may be selected from the group consisted of halogen, C1-C5 alkyl group, cyano (CN), trifluoromethyl (CF3), alkylamino group, amino and alkoxy group. The present invention may be used for anti-oxidant and/or decreasing the toxicity of the nanoparticle. A preparation method of surface modified nanoparticle is also herein provided.

Abstract: The present invention relates to the fields of chemistry and pharmaceuticals. Embodiments of the present invention provide transition metal complexes of amino acids. Transition metal complexes of embodiments of the invention according to Categories I, II, III, and/or IV may be used as antimicrobial, anti-malarial, and anti-cancer agents, as well as catalysts in chemical reactions. Such compounds of the invention are particularly useful for combating multi-drug resistance against a broad range of microbials (such as MRSA and mycobacteria), including gram positive and gram negative bacteria, as well as can be used as anti-cancer agents against bladder cancer, breast cancer, colon cancer, rectal cancer, endometrial cancer, kidney cancer, leukemia, lung cancer, melanoma, non-Hodgkin's lymphoma, pancreatic cancer, prostate cancer, and thyroid cancer, to name a few.

Abstract: Embodiments of the present disclosure provide for nanoparticles, methods of making nanoparticles, methods of using the nanoparticles, and the like. Nanoparticles of the present disclosure can have a variety of morphologies, which may lead to their use in a variety of technologies and processes. Nanoparticles of the present may be used in sensors, optics, mechanics, circuits, and the like. In addition, nanoparticles of the present disclosure may be used in catalytic reactions, for CO oxidation, as super-capacitors, in hydrogen storage, and the like.

Abstract: The present invention generally relates to metal-ligand complexes, catalysts comprising or prepared from the metal-ligand complexes, processes of catalyzing olefin polymerization reactions with the catalysts to prepare polyolefins, polyolefins prepared thereby, processes of making the metal-ligand complexes and catalysts, and intermediate compounds useful therefor.

Abstract: Disclosed are water-soluble nanoparticles. The water-soluble nanoparticles are each surrounded by a multifunctional group ligand including an adhesive region, a cross linking region, and a reactive region. In the water-soluble nanoparticles, the cross-linking region of the multifunctional group ligand is cross-linked with another cross-linking region of a neighboring multifunctional group ligand.

Abstract: A method of producing Prussian blue metal complex nanoparticles and Prussian blue metal complex nanoparticles obtained by the method, a dispersion of the nanoparticles, a method of regulating the color of the nanoparticles, and an electrode and a transmitted light-regulator each using the nanoparticles. Prussian blue metal complex nanoparticles are produced by: mixing an aqueous solution containing a metal cyano complex anion having metal atom MA as a central metal and an aqueous solution containing a cation of metal atom MB; thereby precipitating the crystal of a Prussian blue metal complex having the metal atom MA and the metal atom MB; and then mixing the Prussian blue metal complex with an aqueous solution containing a metal cyano complex anion having the metal atom MC as a central metal and/or an aqueous solution containing a cation of the metal atom MD.

Abstract: An allyl acetate production catalyst comprising at least (a) palladium, (b) gold, (c) a compound containing at least one element selected from copper, nickel, zinc and cobalt, (d) an alkali metal salt compound and (e) a carrier, is produced by a process comprising step 1 in which a homogeneous solution of a palladium-containing compound and a gold-containing compound is supported on a carrier by contact therewith, step 2 in which the carrier obtained in step 1 is contacted with an alkali solution for impregnation, step 3 in which the carrier obtained in step 2 is subjected to reduction treatment, and step 4 in which a compound containing at least one element selected from copper, nickel, zinc and cobalt and an alkali metal salt compound are supported onto the carrier obtained in step 3. The obtained allyl acetate production catalyst has minimal reduction in activity and improved selectivity, when used for production of allyl acetate from propylene, oxygen and acetic acid.

Abstract: Provided are an organometallic precursor, wherein a carboxyhydrazide compound is coordinated to a central metal, and a metal film or pattern using the precursor. By using the organometallic precursor, highly pure metal films or patterns can be obtained through a simple low-temperature process.

Abstract: A metal complex represented by the following formula (1): wherein R1 to R6 each independently represent a hydrogen atom or a substituent; Y1 and Y2 each independently represent any one of the following groups: wherein R? represents a hydrogen atom or a hydrocarbon group having 1 to 4 carbon atoms; P1 and P2 each represent a group of atoms necessary for forming a heterocyclic ring together with Y1 or Y2 and the two carbon atoms at a position adjacent to Y1 or Y2; P1 and P2 may be linked to each other to form a ring; M represents a transition metal element or typical metal element; m represents 1 or 2; X represents a counter ion or a neutral molecule; n represents the number of X's in the complex, and an integer of 0 or more; and Q1 and Q2 each independently represent an aromatic heterocyclic group.

Abstract: This invention relates to the use of nano-organocatalysts, and, more specifically, to the use of magnetic nanomaterial-supported organocatalysts. It is an object of the present invention to provide “green” catalysts and protocols. According to one embodiment of the invention, a nano-organocatalyst in the form of a magnetic nanomaterial-supported organocatalyst is provided. According to other embodiments of the invention, glutathione and cysteine are provided as organocatalysts and magnetic nanomaterial-supported glutathione and magnetic nanomaterial-supported cysteine are provided for use as nano-organocatalysts. According to another embodiment of the invention, a method of using a recyclable magnetic nanomaterial-supported organocatalyst using a totally benign aqueous protocol, without using any organic solvent in the reaction or during the workup, is provided.

Abstract: The invention provides magnetic nanoparticles comprising a core, wherein the nanoparticles comprise at least one therapeutic agent linked to the core via a hydrazone linkage or via an oxime ether linkage, methods for making said nanoparticles, and methods for using said nanoparticles.

Abstract: The present invention relates to a catalyst precursor for the production of odd olefins having the formula: wherein X and Y are halogen and n is 2 or 3; and to a process for its preparation and a method for oligomerization of ethylene.

Abstract: Porous organic-inorganic hybrid materials with crystallinity and a method for preparing the same are provided. The method comprises preparing a reaction solution containing a mixture of at least one inorganic metal precursor, at least one organic compound which may act as a ligand, and a solvent (step 1); and forming porous organic-inorganic hybrid materials with crystallinity by reacting the reaction solution (step 2), wherein the reaction is carried out under the pressure of about 3 atm or less.

Abstract: Process for the preparation of monoimine compounds, wherein a dicarbonyl compound is reacted in an aliphatic, non-aromatic solvent with aniline. Monoimine compounds having electron-withdrawing substituents in the ortho position and unsymmetric bis(imino) compounds and unsymmetric iron complexes prepared therefrom and the use thereof in the polymerization of olefins.

Abstract: Metal-ligand combination initiators are provided which yield organometallic complexes capable of the polymerization of olefins to high molecular weight polymers. Additionally, these initiators also enable the copolymerization of olefins with functionalized comonomers. These organometallic complexes comprise of a late transition metal with a neutral chelating ligand that contains a Lewis basic functionality in conjugation with an electronically delocalized conduit extending from the metal to the functionality. This structural feature results in a highly active complex, which generates high molecular weight polymers with unique microstructures. Under particular conditions, the organometallic complexes provide for the living polymerization of monomers and comonomers.